Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma

OBJECTIVE: To evaluate the efficacy of temozolomide (TMZ) chemotherapy for recurrent anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA). METHODS: A multi-center retrospective trial enrolled seventy-two patients with histologically proven AO/AOA who underwent TMZ chemotherapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwak, Ho-Shin, Yee, Gi Taek, Park, Chul-Kee, Kim, Jin Wook, Hong, Yong-Kil, Kang, Seok-Gu, Kim, Jeong Hoon, Seol, Ho Jun, Jung, Tae-Young, Chang, Jong Hee, Yoo, Heon, Hwang, Jeong-Hyun, Kim, Se-Hyuk, Park, Bong Jin, Hwang, Sun-Chul, Kim, Min Su, Kim, Seon-Hwan, Kim, Eun-Young, Kim, Ealmaan, Kim, Hae Yu, Ko, Young-Cho, Yun, Hwan Jung, Youn, Ji Hye, Kim, Juyoung, Lee, Byeongil, Lee, Seung Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Neurosurgical Society 2013
Materias:
Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921276/
https://www.ncbi.nlm.nih.gov/pubmed/24527191
http://dx.doi.org/10.3340/jkns.2013.54.6.489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921276/
https://www.ncbi.nlm.nih.gov/pubmed/24527191
http://dx.doi.org/10.3340/jkns.2013.54.6.489

Ejemplares similares